Search Results - "Konoplya, A. I."

Refine Results
  1. 1

    CORRELATION ANALYSIS BETWEEN LABORATORY IMMUNE AND METABOLIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA STAGES I AND II ALONG WITH HYPERTENSION AFTER TREATMENT by Bystrova, N. A., Shulginova, A. A., Konoplya, A. I.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (19-10-2021)
    “…Determination of interrelationships between impairments of laboratory parameters of immune and metabolic status in patients with chronic cerebral ischemia of…”
    Get full text
    Journal Article
  2. 2

    rs11927381 Polymorphism and Type 2 Diabetes Mellitus: Contribution of Smoking to the Realization of Susceptibility to the Disease by Azarova, I. E., Klyosova, E. Yu, Lazarenko, V. A., Konoplya, A. I., Polonikov, A. V.

    “…In the study that included 579 patients with type 2 diabetes mellitus and 542 healthy individuals from Slavonic population, an association was found between…”
    Get full text
    Journal Article
  3. 3

    PERSONALIZED PHARMACOLOGICAL CORRECTION OF IMMUNE SYSTEMS, METABOLIC AND NEUROPSYCHIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA OF STAGE I AND II ON THE BACKGROUND OF HYPERTENSION DISEASE by Konoplya, A. I., Shulginova, A. A., Bystrova, N. A., Gavrilyuk, V. P., Ryzhikova, G. N.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (19-10-2021)
    “…The study aimed to develop a personalized pharmacological correction of immune, metabolic and neuropsychiatric disorders in chronic cerebral ischemia (CCI)…”
    Get full text
    Journal Article
  4. 4

    Relationship between metabolic and immunological disorders in experimental acute tetrachlomethane, ischemic and alcoholic liver disease by Litvinova, E S, Konoplya, A I, Kholimenko, I M, Gavriliuk, V P, Kocar, A G

    Published in Biomeditsinskaia khimiia (01-09-2020)
    “…The aim of this study was to investigate the relationship of metabolic and immunological disorders in acute tetrachlomethane, ischemic and alcoholic liver…”
    Get more information
    Journal Article
  5. 5

    Local immune and oxidative status in exacerbated chronic apical periodontitis by Konoplya, A I, Goldobin, D D, Loktionov, A L

    Published in Stomatologija (Moskva) (2017)
    “…The aim of the study was to define local immune and oxidative changes in patients with exacerbated chronic apical periodontitis. These changes were assessed in…”
    Get more information
    Journal Article
  6. 6

    CORRECTION OF IMMUNE DISTURBANCES IN CHRONIC CEREBRAL ISCHEMIA by Shulginova, A. A., Konoplya, A. I., Bystrova, N. A., Gavriliuk, V. P., Karaulov, A. V.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (10-06-2018)
    “…The aim of the study was to determine efficiency of Glutoxim, aimed for correction of immune disorders. The drug was administered to the patients with chronic…”
    Get full text
    Journal Article
  7. 7

    THE RELATIONSHIP OF THE IMMUNE AND METABOLIC DISORDERS DURING VARIOUS METHODS OF MULTICOMPONENT GENERAL ANESTHESIA IN LAPAROSCOPIC CHOLECYSTECTOMY by Konoplya, A I, Sumin, S A, Gavrilyuk, V P, Komissinskaya, L S

    Published in Anesteziologiia i reanimatologiia (01-11-2016)
    “…In addition to operating injury in the pathogenesis of immunological and metabolic disorders after surgical interventions anesthesia plays an important role…”
    Get more information
    Journal Article
  8. 8

    PHARMACOLOGICAL CORRECTION OF RED BLOOD CELL MEMBRANE LIPID SPECTRUM IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA ON THE BACKGROUND OF HYPERTENSIVE DISEASE. by Shul'ginova, A A, Laskov, V B, Konoplya, A I, Karaulov, A V

    “…In patients with chronic cerebral ischemia on the background of hypertension grade 2, stage 2, our investigation revealed a significant decrease (by 30.1%) in…”
    Get more information
    Journal Article
  9. 9

    Immune and oxygen disturbances in patients with chronic cerebral ischemia and their correction by Konoplya, A I, Laskov, V B, Shul'ginova, A A

    “…To determine the dynamics of immunometabolic characteristics in patients with chronic ischemia of the brain (discirculatory encephalopathy - DE) under the…”
    Get more information
    Journal Article
  10. 10

    The application of intravascular laser irradiation of blood for the correction of the immune disturbances in patients presenting with chronic endometritis by Konoplya, A A, Gavrish, S A, Konoplya, A I, Loktionov, A L

    “…The objective of the present study was to elucidate the specific features of the immune disturbances in patients presenting with chronic endometritis and to…”
    Get more information
    Journal Article
  11. 11

    IMMUNE AND METABOLIC DISTURBANCES IN EXPERIMENTAL ACUTE TOXIC HEPATITIS: CORRECTION BY XENOGENIC AND ALLOGENIC HEPATOCYTES by A. I. Konoplya, E. S. Litvinova, N. A. Bystrova, M. S. Razumova, T. V. Chuyeva

    “…For correspondence: Konoplya Alexander Ivanovich. Address: 3,K. Marx St.,Kursk, 305041,Russian Federation. Tel.: job. (4712) 58-81-76; mob. (910) 317-87-88…”
    Get full text
    Journal Article
  12. 12

    CORRECTION OF IMMUNE DISTURBANCES IN CHRONIC CEREBRAL ISCHEMIA by Shulginova, A A, Konoplya, A I, Bystrova, N A, Gavriliuk, V P, Karaulov, A V

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-01-2018)
    “…The aim of the study was to determine efficiency of Glutoxim, aimed for correction of immune disorders. The drug was administered to the patients with chronic…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Tripeptide Gly-His-Lys is a hepatotropic immunosuppressor by Smakhtin, M Yu, Sever'yanova, L A, Konoplya, A I, Shveinov, I A

    “…Ten intraperitoneal injections of tripeptide Gly-His-Lys in doses of 1.5, 5, 50, 150, and 450 mg/kg stimulated mitotic activity of hepatocytes and…”
    Get full text
    Journal Article
  15. 15

    MECHANISM OF USING RRO AND PRO IN CONDITIONS OF INCREASING THE LEVEL OF TAX ADMINISTRATION by Poberezhets, O. V., Shmagina, V. V., Konoplya, A. I.

    “…The article investigates the theoretical and methodological principles of the mechanism of using RRO and PRRO in terms of increasing the level of tax…”
    Get full text
    Journal Article
  16. 16

    DSLET and ACTH4-10 Increase Mitotic Activity of Hepatocytes and Suppress Antibody Production by M. Yu. Smakhtin, Konoplya, A I, Sever'yanova, L A, Shveinov, I A

    “…The mitotic index of hepatocytes remained unchanged after 10 intraperitoneal injections of DSLET and ACTH(4-10) in doses of 0.5, 1.5, and 5 microg/kg, but…”
    Get full text
    Journal Article
  17. 17

    Polymorphisms of the Gene Encoding Cytochrome b-245 Beta Chain of NADPH Oxidase: Relationship with Redox Homeostasis Markers and Risk of Type 2 Diabetes Mellitus by Azarova, I. E., Klyosova, E. Yu, Kolomoets, I. I., Azarova, V. A., Ivakin, V. E., Konoplya, A. I., Polonikov, A. V.

    Published in Russian journal of genetics (01-07-2020)
    “…The aim of this study was to investigate the associations of the single-nucleotide polymorphisms (SNPs) rs5917471, rs5963327 and rs6610650 of the gene encoding…”
    Get full text
    Journal Article
  18. 18

    Immune disturbances in acute pyelonephritis. Part I by Shatokhin, M N, Konoplya, A I, Kholimenko, I M, Besprozvanniy, V I, Mavrin, M Yu

    Published in Urologii͡a︡ (Moscow, Russia : 1999) (06-12-2019)
    “…In the part I of a literature review of modern national and foreign publications dedicated to the problem of immune disorders in acute pyelonephritis,…”
    Get more information
    Journal Article
  19. 19

    DSLET and ACTH(4-10) increase mitotic activity of hepatocytes and suppress antibody production by Smakhtin, M Yu, Konoplya, A I, Sever'yanova, L A, Shveinov, I A

    “…The mitotic index of hepatocytes remained unchanged after 10 intraperitoneal injections of DSLET and ACTH(4-10) in doses of 0.5, 1.5, and 5 microg/kg, but…”
    Get full text
    Journal Article
  20. 20

    Condition of the immune status at patients with the serous and purulent pyelonephritis according by Konoplya, A I, Bratchikov, O I, Kholimenko, I M, Shatokhin, M N, Dzharimok, A R, Mavrin, M Yu, Loktionov, A L

    Published in Urologii͡a︡ (Moscow, Russia : 1999) (01-04-2016)
    “…Studying of a condition of the immune status on for standard treatment at an acute serous and purulent pyelonephritis. The immune status of 62 patients with…”
    Get more information
    Journal Article